DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) Ongoing Study

To test an integrated approach for promoting effective self management in people with established Type 2 Diabetes Mellitus (T2DM): a cluster randomised controlled trial of the DESMOND Ongoing education programme

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN71467886

Enrollment

532

Registered

2011-03-03

Start date

2011-01-01

Completion date

Unknown

Last updated

2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus (T2DM) Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus

Interventions

Patients in the intervention group will receive the following: 1. DESMOND Foundation. An existing DESMOND 6-hour group education course which provides introductory information for mana

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Current participant inclusion criteria as of 04/02/2019: 1. Individuals with established Type 2 Diabetes Mellitus 2. Diabetes duration of 12 months or more 3. HbA1c between 7.8 and 11% Previous participant inclusion criteria: 1. Individuals with established Type 2 Diabetes Mellitus 2. Diabetes duration of 12 months or more 3. HbA1c between 7.0 and 11%

Exclusion criteria

Exclusion criteria: 1. Receiving insulin therapy 2. Have existing comorbidities that could interfere with participation in the study over the 24 months 3. Unable to give informed consent 4. Severe and enduring mental health problems 5. Patients who are not primarily responsible for their own care 6. Unable to participate in a group programme (e.g. housebound) 7. Insufficient understanding of English to participate in the group education 8. Visually impaired or hard of hearing to the level that they can not participate in the group education 9. Aged under 18 years

Design outcomes

Primary

Measure	Time frame
Reduction in HbA1c at 24 months	—

Secondary

Measure	Time frame
1. Reduction in the following biomedical measures measured at 12 and 24 months 1.1. HbA1c (at 12 months) 1.2. Cholesterol (total, HDL and LDL) 1.3. Triglyceride 1.4. Blood pressure (BP) Systolic 1.5. BP Diastolic 1.6. Weight 1.7. Waist circumference 1.8. Hip circumference 2. Improvement in the following scores at 12 and 24 months 2.1. EQ5D 2.2. Illness Perceptions Questionnaire revised 2.3. Diabetes Illness Representations Questionnaire 2.4. Summary of Diabetes Self Care Activities questionnaire 2.5. Hospital Anxiety and Depression Score 2.6. Problem Areas in Diabetes Score 2.7. International Physical Activity Questionnaire	—

Measure

Time frame

1. Reduction in the following biomedical measures measured at 12 and 24 months 1.1. HbA1c (at 12 months) 1.2. Cholesterol (total, HDL and LDL) 1.3. Triglyceride 1.4. Blood pressure (BP) Systolic 1.5. BP Diastolic 1.6. Weight 1.7. Waist circumference 1.8. Hip circumference 2. Improvement in the following scores at 12 and 24 months 2.1. EQ5D 2.2. Illness Perceptions Questionnaire revised 2.3. Diabetes Illness Representations Questionnaire 2.4. Summary of Diabetes Self Care Activities questionnaire 2.5. Hospital Anxiety and Depression Score 2.6. Problem Areas in Diabetes Score 2.7. International Physical Activity Questionnaire

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026